People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vergent Bioscience, Inc. | — | Biotechnology | Series B | $57.0M | $77.2M | 2018 |
| MicroCHIPS, Inc. | — | Biotechnology | Series B | $27.9M | $740.1M | 2009 |
| ApoGen Biotechnologies, Inc. | — | Biotechnology | Series A | $7.6M | $273.5M | 2016 |
| On Demand Therapeutics, Inc. | — | Biotechnology | Seed | $3.8M | $116.5M | 2009 |
| Accord Biomaterials Inc | — | Biotechnology | Seed | $1.2M | $53.3M | 2010 |
John Santini at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Santini on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John T. Santini, Jr. | 2 | 2 |
| Robert Langer | 1 | 36 |
| Asish Xavier | 1 | 18 |
| Michael Greeley | 1 | 15 |
| Robert S Langer | 1 | 14 |
| Steve Gillis | 1 | 13 |
| Thong Le | 1 | 12 |
| Joel Marcus | 1 | 9 |
| Terrance McGuire | 1 | 9 |
| Jan Garfinkle | 1 | 7 |
| TERRANCE G. MCGUIRE | 1 | 7 |
| James Sullivan | 1 | 7 |
| Lindsay Rayle | 1 | 7 |
| Robert Crane | 1 | 7 |
| David Schubert | 1 | 6 |
| Joel Johnston Marcus | 1 | 5 |
| M. Johnston Erwin | 1 | 5 |
| Raymond Wong | 1 | 4 |
| Cheryl R. Blanchard | 1 | 4 |
| Douglas Kohrs | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.